Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SGN-B7H4V |
Trade Name | |
Synonyms | SGN B7H4V|SGNB7H4V |
Drug Descriptions |
SGN-B7H4V is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody targeting VTCN1 (B7-H4) linked to monomethyl auristatin E (MMAE), which potentially induces cytotoxicity, phagocytosis, and tumor growth inhibition (Cancer Res 2022;82(12_Suppl):Abstract nr 1281). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C186669 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
SGN-B7H4V | SGN-B7H4V | 0 | 1 |